19-8580654-A-AG
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_030957.4(ADAMTS10):c.*238dupC variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.102 in 506,206 control chromosomes in the GnomAD database, including 2,958 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.096 ( 813 hom., cov: 29)
Exomes 𝑓: 0.10 ( 2145 hom. )
Consequence
ADAMTS10
NM_030957.4 3_prime_UTR
NM_030957.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.89
Genes affected
ADAMTS10 (HGNC:13201): (ADAM metallopeptidase with thrombospondin type 1 motif 10) This gene belongs to the ADAMTS (a disintegrin and metalloproteinase domain with thrombospondin type-1 motifs) family of zinc-dependent proteases. ADAMTS proteases are complex secreted enzymes containing a prometalloprotease domain of the reprolysin type attached to an ancillary domain with a highly conserved structure that includes at least one thrombospondin type 1 repeat. They have been demonstrated to have important roles in connective tissue organization, coagulation, inflammation, arthritis, angiogenesis and cell migration. The product of this gene plays a major role in growth and in skin, lens, and heart development. It is also a candidate gene for autosomal recessive Weill-Marchesani syndrome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 19-8580654-A-AG is Benign according to our data. Variant chr19-8580654-A-AG is described in ClinVar as [Likely_benign]. Clinvar id is 330572.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.126 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS10 | NM_030957.4 | c.*238dupC | 3_prime_UTR_variant | 26/26 | ENST00000597188.6 | NP_112219.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS10 | ENST00000597188 | c.*238dupC | 3_prime_UTR_variant | 26/26 | 5 | NM_030957.4 | ENSP00000471851.1 | |||
ADAMTS10 | ENST00000270328 | c.*238dupC | 3_prime_UTR_variant | 25/25 | 5 | ENSP00000270328.4 | ||||
ADAMTS10 | ENST00000595838 | c.*238dupC | 3_prime_UTR_variant | 13/13 | 2 | ENSP00000470501.1 | ||||
ADAMTS10 | ENST00000593913.5 | n.*2427dupC | downstream_gene_variant | 5 | ENSP00000469901.1 |
Frequencies
GnomAD3 genomes AF: 0.0963 AC: 14551AN: 151178Hom.: 808 Cov.: 29
GnomAD3 genomes
AF:
AC:
14551
AN:
151178
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.105 AC: 37249AN: 354908Hom.: 2145 Cov.: 1 AF XY: 0.103 AC XY: 19480AN XY: 189260
GnomAD4 exome
AF:
AC:
37249
AN:
354908
Hom.:
Cov.:
1
AF XY:
AC XY:
19480
AN XY:
189260
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0963 AC: 14569AN: 151298Hom.: 813 Cov.: 29 AF XY: 0.0946 AC XY: 6996AN XY: 73918
GnomAD4 genome
AF:
AC:
14569
AN:
151298
Hom.:
Cov.:
29
AF XY:
AC XY:
6996
AN XY:
73918
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
245
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Weill-Marchesani syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 31, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at